✨ Free AI Report
Syrrx, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Company Research

Syrrx, Inc.: Business Overview, Financials & Competitive Analysis

Historical biotech innovator in structural biology acquired and integrated into larger pharmaceutical organization. Syrrx ceased independent operations following its February 2005 acquisition by Takeda Pharmaceuticals. As a subsidiary, the company's autonomous business metrics and strategic positioning are no longer independently measurable.

What is Syrrx, Inc.'s industry? Syrrx, Inc. (syrrx.com) operates in Drug Discovery Services. AskCyborg classifies Syrrx, Inc. under Drug Discovery Services in its company registry.

Syrrx, Inc. was a San Diego-based structural proteomics and drug discovery company founded in 1999 that specialized in high-throughput X-ray crystallography for rapid drug discovery. The company developed proprietary ...

Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest Syrrx, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Syrrx, Inc.

AskCyborg analysts argue the bull and bear cases for Syrrx, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Syrrx, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Syrrx, Inc. Overview

Pro stress-test →

Syrrx, Inc. was a San Diego-based structural proteomics and drug discovery company founded in 1999 that specialized in high-throughput X-ray crystallography for rapid drug discovery. The company developed proprietary 'gene to drug' platforms enabling rational drug design based on three-dimensional protein structures. Syrrx was acquired by Takeda Pharmaceuticals in February 2005 for $270 million and subsequently integrated into Takeda's US research operations.

Strategic Profile

Pro stress-test →

Syrrx's core competitive advantage was its automated systems for protein structure determination and rational drug discovery targeting validated human clinical trial targets. The company focused on small molecule inhibitors for cancer, metabolic diseases (particularly Type 2 diabetes), and inflammation, with partnerships including Novartis and ongoing DPP IV inhibitor development programs.

Competitive Landscape

Pro stress-test →

As an acquired subsidiary integrated into Takeda's operations since 2005, Syrrx no longer operates as an independent competitive entity. Historically, it competed with other structure-based drug discovery platforms and contract research organizations in the protein crystallography and rational drug design space.

Industry Context

Syrrx, Inc. operates in Drug Discovery Services.

Key facts

Founded: 1999 · Headquarters: San Diego, US · Revenue: $10.4 million (2026, as subsidiary)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Syrrx, Inc..

  • Founded in 1999 with focus on high-throughput X-ray crystallography for structure-guided drug discovery
  • Acquired by Takeda in February 2005, becoming Takeda's entry point to US research operations
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2005Acquired by Takeda Pharmaceuticals for $270 million
  • 2001Strategic alliance formed with Novartis Genomics Institute for automated protein structure analysis
Get alerted when Syrrx, Inc. has a new material development →

Compare Syrrx, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Syrrx, Inc. operates in Drug Discovery Services. See how the rest of the sector scores on the Cyborg framework.

Browse Drug Discovery Services research →
NEW · MCP server

Ask your AI assistant about Syrrx, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Syrrx, Inc. and its top competitor on Cyborg Score”
“What did Syrrx, Inc. do this quarter?”
“Is Syrrx, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Syrrx, Inc. do?+
Syrrx, Inc. was a San Diego-based structural proteomics and drug discovery company founded in 1999 that specialized in high-throughput X-ray crystallography for rapid drug discovery. The company developed proprietary ...
What is Syrrx, Inc.'s Cyborg Score?+
The Cyborg Score is a 1-10 rating from the AskCyborg multi-agent analyst-debate framework. Recalibrated weekly across business, financials, leadership, competitive position, technology, marketing, and ESG dimensions.
Who are Syrrx, Inc.'s main competitors?+
The full competitive landscape for Syrrx, Inc. is in the AskCyborg report.
How can I get the full Syrrx, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Syrrx, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.